Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies ; volume:23 ; number:1 ; day:29 ; month:8 ; year:2022 ; pages:1-9 ; date:12.2022
The journal of headache and pain ; 23, Heft 1 (29.8.2022), 1-9, 12.2022
- Creator
-
McAllister, Peter
Cohen, Joshua M.
Campos, Verena Ramirez
Ning, Xiaoping
Janka, Lindsay
Barash, Steve
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-022-01438-4
- URN
-
urn:nbn:de:101:1-2022111621002476336418
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McAllister, Peter
- Cohen, Joshua M.
- Campos, Verena Ramirez
- Ning, Xiaoping
- Janka, Lindsay
- Barash, Steve
- SpringerLink (Online service)
Other Objects (12)
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Episodic Migraine and Older Adults
Depression and risk of transformation of episodic to chronic migraine
Vestibular migraine: the most frequent entity of episodic vertigo
The borderland of migraine with aura: episodic unilateral mydriasis
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results
Sex and Gender Considerations in Episodic Migraine
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Pediatric migraine and episodic syndromes that may be associated with migraine
Analysis of the ocular surface functional unit in episodic migraine
Prevalence of trigeminocervical convergence mechanisms in episodic and chronic migraine
Disrupted functional connectivity of periaqueductal gray subregions in episodic migraine
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Episodic Migraine and Older Adults
Depression and risk of transformation of episodic to chronic migraine
Vestibular migraine: the most frequent entity of episodic vertigo
The borderland of migraine with aura: episodic unilateral mydriasis
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results
Sex and Gender Considerations in Episodic Migraine
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Pediatric migraine and episodic syndromes that may be associated with migraine
Analysis of the ocular surface functional unit in episodic migraine
Prevalence of trigeminocervical convergence mechanisms in episodic and chronic migraine
Disrupted functional connectivity of periaqueductal gray subregions in episodic migraine
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Episodic Migraine and Older Adults
Depression and risk of transformation of episodic to chronic migraine
Vestibular migraine: the most frequent entity of episodic vertigo
The borderland of migraine with aura: episodic unilateral mydriasis
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results
Sex and Gender Considerations in Episodic Migraine
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Pediatric migraine and episodic syndromes that may be associated with migraine
Analysis of the ocular surface functional unit in episodic migraine
Prevalence of trigeminocervical convergence mechanisms in episodic and chronic migraine